4.2 Transmission-Based Precautions & Isolation Protocols

4.2 Transmission-Based Precautions & Isolation Protocols

Quick Answer: Transmission-Based Precautions are the second tier of infection prevention, used in addition to Standard Precautions for patients with documented or suspected infections with highly transmissible or epidemiologically important pathogens. Categorized into Contact, Droplet, and Airborne Precautions, these protocols specify required personal protective equipment (PPE), patient placement, room ventilation standards, and transport restrictions. Empiric isolation must be initiated immediately based on clinical presentation prior to laboratory confirmation.

While Standard Precautions reduce cross-transmission risks across general patient populations, certain microorganisms possess transmission routes—such as small-particle aerosols, heavy respiratory droplets, or durable environmental spores—that require specialized barrier protocols. Infection Preventionists play a critical role in establishing, auditing, and maintaining isolation protocols across healthcare settings.

---

Overview and Syndromic Isolation

Transmission-Based Precautions are applied based on the mode of transmission of specific pathogens. A cornerstone of effective infection control is syndromic or empiric isolation: placing patients in appropriate isolation at the first clinical suspicion of a transmissible infection rather than waiting for diagnostic laboratory test results.

Clinical Triggers for Empiric Isolation

• Acute flaccid paralysis or rash with fever: Empiric Airborne + Contact Precautions (suspected measles, varicella, or smallpox).
• Unexplained diarrhea or history of recent antibiotic exposure: Empiric Contact Precautions (suspected C. difficile or enteric viral infection).
• Cough, fever, and pulmonary infiltrate in a patient with risk factors for tuberculosis: Empiric Airborne Precautions in an AIIR.
• Petechial or purpuric rash with fever and meningeal signs: Empiric Droplet Precautions (suspected Neisseria meningitidis).

---

Categories of Transmission-Based Precautions

1. Contact Precautions

Contact Precautions prevent transmission of infectious agents spread by direct contact with the patient or indirect contact with environmental surfaces or patient care items in the patient's environment.

• Target Pathogens: Multidrug-resistant organisms (MDROs such as MRSA, VRE, ESBL-producing Enterobacterales, carbapenem-resistant Enterobacterales [CRE]), Clostridioides difficile, Candida auris, scabies, respiratory syncytial virus (RSV), and impetigo.
• Required PPE: Gown and gloves upon entry into the patient room.
• Patient Placement: Single private room preferred. If unavailable, cohort patients infected with the exact same pathogen.
• Equipment Management: Dedicate non-critical patient care equipment (e.g., blood pressure cuffs, stethoscopes, thermometers) to the individual patient. Clean and disinfect reusable equipment with EPA-registered disinfectants before use on another patient.

2. Droplet Precautions

Droplet Precautions prevent transmission of pathogens spread through close respiratory or mucous membrane contact with large-particle respiratory droplets (>5 micrometers in size) generated during coughing, sneezing, talking, or suctioning. Droplets travel short distances (typically 3 to 6 feet) and do not remain suspended in the air.

• Target Pathogens: Neisseria meningitidis, influenza, Bordetella pertussis, mumps, rubella, parvovirus B19, and Group A Streptococcus pharyngitis/pneumonia.
• Required PPE: Surgical / procedure mask upon entry into the room. Eye protection (goggles or face shield) if splashing or spraying of secretions is anticipated.
• Patient Placement: Single private room preferred. Maintain spatial separation of at least 3 to 6 feet between patients if cohorting is necessary.
• Patient Transport: Limit transport outside the room. If transport is mandatory, place a surgical mask on the patient and instruct them on cough etiquette.

3. Airborne Precautions

Airborne Precautions prevent transmission of infectious agents that remain infectious over time and distance when suspended in the air as small-particle droplet nuclei (≤5 micrometers in size).

• Target Pathogens: Mycobacterium tuberculosis (TB), measles (rubeola), varicella-zoster virus (chickenpox), and disseminated herpes zoster.
• Required PPE: Fit-tested N95 filtering facepiece respirator or higher-level protection (e.g., Powered Air-Purifying Respirator [PAPR]) for all healthcare personnel entering the room.
• Patient Placement: Airborne Infection Isolation Room (AIIR) with specialized negative pressure ventilation.
• Patient Transport: Limit transport outside the room. If transport is essential, the patient must wear a surgical mask (not an N95, which has an exhalation valve or increases breathing resistance) to contain respiratory secretions.

---

Isolation Category Comparison Matrix

---

Engineering Standards for Airborne Infection Isolation Rooms (AIIR)

Airborne Infection Isolation Rooms require specific HVAC engineering controls to prevent the escape of airborne droplet nuclei into adjacent corridors or patient care spaces.

Key AIIR Engineering Specifications

• Negative Air Pressure: Air pressure inside the AIIR must be negative relative to the surrounding hallway or anteroom. Air flows inward into the room when the door is opened (minimum pressure differential of -2.5 Pascals or -0.01 inches water gauge).
• Air Changes per Hour (ACH):
  • New Construction / Renovated Facilities: Minimum of 12 ACH.
  • Existing Facilities: Minimum of 6 ACH.
• Exhaust Air Management: Air from an AIIR must be directly exhausted to the outside of the building away from air intake vents and public areas. If direct outdoor exhaust is impossible, air must pass through a certified High-Efficiency Particulate Air (HEPA) filter (removing 99.97% of particles down to 0.3 µm) prior to recirculation.
• Continuous Pressure Monitoring: Visual monitoring devices (ball-in-tube, digital manometer, or daily smoke tube testing) must verify negative pressure status continuously or daily while occupied.

Protective Environment (Positive Pressure Rooms)

A Protective Environment (PE) is designed for severely immunocompromised patients (e.g., allogeneic hematopoietic stem cell transplant recipients) to protect them from environmental fungal spores (Aspergillus species). PE rooms feature positive air pressure relative to hallways (air flows outward), HEPA filtration of supply air, and ≥12 ACH.

---

Special Pathogen Focus: MDROs, C. auris, & Cohorting

Candida auris Infection Control

Candida auris is an emerging multidrug-resistant yeast that causes severe invasive infections and presents unique infection control challenges:

• Environmental Persistence: Persists on healthcare surfaces for weeks and resists standard quaternary ammonium disinfectants.
• Disinfection Protocol: Requires an EPA-registered hospital disinfectant from List P (specifically effective against C. auris) or List K (sporicidal disinfectants effective against C. difficile).
• Precautions: Implement strict Contact Precautions and place patients in single rooms.

Cohorting Principles

When single rooms are unavailable during high census or outbreaks, cohorting may be utilized under strict conditions:

• Identical Pathogen Rule: Only cohort patients infected or colonized with the exact same pathogen (e.g., two MRSA-colonized patients).
• Resistance Profile Verification: Do not cohort patients with different resistance patterns (e.g., do not cohort a patient with vancomycin-susceptible enterococcus with a patient carrying VRE).
• Avoid Cohorting High-Risk Patients: Never cohort patients with C. difficile, C. auris, or pan-resistant organisms unless sharing a room with a patient carrying the identical strain.